ATX THERAPEUTICS

atx-therapeutics-logo

ATX Therapeutics is a digital health company that empowers people to reach their health goals by enabling healthy behavior changes in individuals who either have, or are at risk of developing chronic diseases, such as cancer, heart disease and chronic obstructive pulmonary disease (COPD). Working with healthcare consumers, providers, researchers, health plans and employers, ATX Therapeutics creates evidence-based digital therapeutic products that deliver positive health outcomes while engaging patients to manage specific chronic health conditions and their associated risk behaviors. The company follows a human-centered and data-driven approach to product design, combining exceptional consumer-grade experiences with clinically-validated interventions to deliver sustainable results.

#SimilarOrganizations #People #Website #More

ATX THERAPEUTICS

Social Links:

Industry:
Health Care

Founded:
2019-07-23

Address:
Austin, Texas, United States

Country:
United States

Website Url:
http://www.atxtherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
8154049424

Email Addresses:
[email protected]

Technology used in webpage:
Gravatar Profiles U.S. Server Location


Similar Organizations

polyfins-technology-inc-logo

PolyFins Technology Inc

Digital therapeutic apps for chronic skin diseases

tiatros-inc-logo

Tiatros Inc.

Digital Therapeutics for Behavioral Health

Founder


adam-falat_image

Adam Falat

Official Site Inspections

http://www.atxtherapeutics.com

Unable to get host informations!!!

Loading ...

More informations about "ATX Therapeutics"

ATXA Therapeutics - Innovation

ATXA Therapeutics is a clinical-stage pharmaceutical company committed to the advancement of innovative, life-changing treatments for cardiopulmonary diseases. Our research focuses on developing novel antagonists of the …See details»

ATXA Therapeutics - Crunchbase Company Profile

Contact Email [email protected] ATXA Therapeutics Limited is a spin-out company from University College Dublin whose primary focus is to …See details»

ATXA Therapeutics - LinkedIn

ATXA Therapeutics is a clinical-stage pharmaceutical company committed to the advancement of innovative, life-changing treatments for cardiopulmonary diseases.See details»

ATXA Therapeutics - PitchBook

ATXA Therapeutics General Information Description. Developer of a clinical-stage pharma company intended for heart and lung conditions that target human thromboxane receptor …See details»

ATXA Therapeutics Ltd - European Commission

Pharmaceutical company focused on the small molecule drug NTP42 for the treatment of pulmonary arterial hypertension (PAH).See details»

ATXA Therapeutics - Overview, News & Similar companies

ATXA Therapeutics contact info: Phone number: +353 877765446 Website: www.atxatherapeutics.com What does ATXA Therapeutics do? ATXA Therapeutics is …See details»

ATXA Therapeutics - About Us

Founded by Professor Therese Kinsella in 2015, ATXA is the culmination of over 20 years of research and extensive, prestigious funding, along with a proven record in elucidating the …See details»

ATXA Therapeutics Information - RocketReach

Atxatherapeutics.com; 1 416357XXXX; View Similar People. Related Companies Maple Clinic. 6 Results Fitness. 7 $5m Learn More How It Works. Get a Free Account. Sign up for a free …See details»

Atxa Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials

Explore Atxa Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 5 literature, Disease Domain:Neoplasms ...See details»

ATX Therapeutics - Crunchbase Company Profile & Funding

ATX Therapeutics is a digital health company that empowers people to reach their health goals by enabling healthy behavior changes in individuals who either have, or are at risk of developing …See details»

ATXA Therapeutics Overview | SignalHire Company Profile

Organization Website: atxatherapeutics.com : Phone Number +353 1 525 2829: ATXA Therapeutics industries Pharma: Headquarters Location: UCD Conway Institute, Belfield, …See details»

Atxa Therapeutics Ltd. (Atxa Therapeutics Ltd.) - 药物管线_专利_临 …

May 7, 2025 Abstract Background NTP42 is a novel antagonist of the thromboxane prostanoid receptor (TP), currently in development for the treatment of pulmonary arterial hypertension …See details»

ATXA Therapeutics - Our Team

The ATXA team has strong expertise in cardiovascular and cancer biology with technical know-how in platelet biology, cellular and molecular biology, protein biology, pathological and …See details»

ATXA Therapeutics Ltd - VentureRadar

ATXA Therapeutics Limited is focusing on clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension (PAH), serving a... ... Find out ...See details»

ATXA Therapeutics Appoints Dr Ivan Coulter as Chief Executive …

Www.atxatherapeutics.com. Pulmonary Arterial Hypertension(PAH) is one form of a broader condition known as pulmonary hypertension, which means high blood pressure in the lungs. In …See details»

ATXA Therapeutics - Our Mission

Driven by innovative research, our aim is to bring accessible, affordable and life-changing treatments to patients with cardiopulmonary diseases, offering them new hope and bettering …See details»

ATXA Therapeutics - News

ATXA will present data from a First-in-Human (FIH) Phase I trial of NTP42:KVA4, a novel formulation of its lead clinical candidate NTP42...See details»

ATXA to Present at ATS International Conference 2023

Apr 28, 2023 ATXA will present data from a First-in-Human (FIH) Phase I trial of NTP42:KVA4, a novel formulation of its lead clinical candidate NTP42 at the American Thoracic Society (ATS) …See details»

ATXA Therapeutics - Our Pipeline

ATXA Therapeutics has developed a novel series of highly selective antagonists of the TP receptor. Amongst ATXA’s TP antagonist series is the lead candidate drug NTP42, as well as …See details»

AtG - stopping cancer metabolic adaptation

Where to find AtG Hospital Duran i Reynals (3rd floor). Av. Gran via 199, 08908. Barcelona, Spain. Call us at +34 932 607 252See details»

linkstock.net © 2022. All rights reserved